SEC Form 4 · accession 0001171000-17-000051
Nexvet Biopharma plc · NVET
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Geraldine T Farrell
Officer — VP Operations, General Counsel
Period of report
Jul 1, 2017
Accepted (ET)
Jul 5, 2017 · 1:30 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001618561
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Ordinary Shares | Jul 1, 2017 | M | 10,000 | $0.125 | A | 16,640 | D | |
| Ordinary Shares | Jul 1, 2017 | M | 2,340 | $0.125 | A | 18,980 | D | |
| Ordinary SharesF1 | Jul 1, 2017 | M | 2,866 | $0.125 | A | 26,986 | I | By Geraldine Therese Farrell & Andrew John Benston <Bulla Bulla Family A/C> |
| Ordinary SharesF1 | Jul 1, 2017 | M | 6,194 | $0.125 | A | 33,180 | I | Geraldine Therese Farrell & Andrew John Benston <Bulla Bulla Family A/C> |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Restricted Share UnitsF2 | $0.125 | Jul 1, 2017 | M | 10,000 | D | Jul 1, 2017 | Jul 1, 2021 | Ordinary Shares | 10,000 | 30,000 | D |
| Restricted Share UnitsF3 | $0.125 | Jul 1, 2017 | M | 2,340 | D | Jul 1, 2017 | Jul 1, 2020 | Ordinary Shares | 2,340 | 4,678 | D |
| Option to Purchase SharesF1 | $0.125 | Jul 1, 2017 | M | 2,866 | D | Jul 1, 2017 | Jul 1, 2019 | Ordinary Shares | 2,866 | 0 | I |
| Option to Purchase SharesF1 | $0.125 | Jul 1, 2017 | M | 6,194 | D | Nov 5, 2016 | Nov 5, 2023 | Ordinary Shares | 6,194 | 0 | I |
Explanation of responses
- F1The reporting person and her spouse have shared voting and dispositive power with respect to these reported securities.
- F210,000 of the Restricted Share Units vested and became convertible on 7/1/17 and 10,000 of the Restricted Share Units shall vest and become convertible on each of 7/1/18, 7/1/19 and 7/1/20, in each case subject to payment of the nominal value per share to Issuer within 30 days of vesting.
- F32,340 of the Restricted Share Units vested and became convertible on 7/1/17 and 2,339 of the Restricted Share Units shall vest and become convertible on each of 7/1/18 and 7/1/19, in each case subject to payment of the nominal value per share to Issuer within 30 days of vesting.